| Kendra Williams, DNP, FNP-C, CRNA | |
|
7535 S Union Park Ave, Midvale, UT 84047-3043 | |
| (801) 391-8432 | |
| Not Available |
| Full Name | Kendra Williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 7535 S Union Park Ave, Midvale, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568768430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 371423-4405 (Utah) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 371423-4406 (Utah) | Primary |
| Entity Name | Rocky Mountain Anesthesiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487683215 PECOS PAC ID: 6305809492 Enrollment ID: O20041109001170 |
News Archive
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
A new research center at Aalborg University in Denmark will investigate how a maladaptive central nervous system can be responsible for the enduring or chronic pain that affects one in five adult Danes. If this major ambition is fulfilled, it may turn the understanding of the pain system on its head and improve treatment.
A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests.
› Verified 5 days ago
| Entity Name | Professional Anesthesia Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235541848 PECOS PAC ID: 3971824798 Enrollment ID: O20150605000410 |
News Archive
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
A new research center at Aalborg University in Denmark will investigate how a maladaptive central nervous system can be responsible for the enduring or chronic pain that affects one in five adult Danes. If this major ambition is fulfilled, it may turn the understanding of the pain system on its head and improve treatment.
A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests.
› Verified 5 days ago
| Entity Name | 321 Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902264427 PECOS PAC ID: 8123323250 Enrollment ID: O20160226000952 |
News Archive
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
A new research center at Aalborg University in Denmark will investigate how a maladaptive central nervous system can be responsible for the enduring or chronic pain that affects one in five adult Danes. If this major ambition is fulfilled, it may turn the understanding of the pain system on its head and improve treatment.
A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendra Williams, DNP, FNP-C, CRNA 1045 E 5950 S, South Ogden, UT 84405-4892 Ph: () - | Kendra Williams, DNP, FNP-C, CRNA 7535 S Union Park Ave, Midvale, UT 84047-3043 Ph: (801) 391-8432 |
News Archive
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
A new research center at Aalborg University in Denmark will investigate how a maladaptive central nervous system can be responsible for the enduring or chronic pain that affects one in five adult Danes. If this major ambition is fulfilled, it may turn the understanding of the pain system on its head and improve treatment.
A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests.
› Verified 5 days ago